1880 S Dairy Ashford Rd, Suite 650, Houston, TX 77077

Neuroscience Market Booms as Brain Health Becomes Global Priority; Expected to Reach USD 70.75 Billion By 2031

The global Neuroscience market size was estimated at USD 45.07 billion in 2023 and is expected to reach USD 70.75 billion by 2031, registering a compound annual growth rate (CAGR) of 5.80% during the forecast period from 2024 to 2031, according to a new market research report by SNS INSIDER.

Rising Prevalence of Neurological Disorders and Increasing R&D Focus Driving Market Expansion

Neuroscience Market
Neuroscience Market

Market Scope:  

The immense potential of neuroscience is overshadowed by the complexity of the brain itself. Developing treatments for neurological disorders is a frustrating maze. Our limited understanding of how these diseases progress makes pinpointing effective drug targets difficult. Even promising medications often fail to clear the blood-brain barrier, a selective gateway that shields the brain.  These hurdles translate to high failure rates in clinical trials, discouraging investment and stalling progress. This creates a vicious cycle – the very diseases that demand innovative solutions stifle the market that could deliver them.

Get Free Sample Report of Neuroscience Market @ https://www.snsinsider.com/sample-request/3936

List of Neuroscience Companies Profiled in Report:

  • Carl Zeiss AG
  • Danaher Corporation
  • GE Healthcare
  • Siemens Healthcare Private Limited
  • Koninklijke Philips N.V.
  • Canon Inc.
  • Braun SE
  • Medtronic
  • Stryker
  • Boston Scientific Corporation
  • Terumo Corporation

Demand Analysis:

The demand for neuroscience-based solutions is undeniably on the rise. This surge can be attributed to the alarming prevalence of neurological disorders like Alzheimer’s disease, Parkinson’s disease, and depression. According to the World Health Organization (WHO), neurological disorders affect nearly one billion people globally, making them a leading cause of disability and death. This growing disease burden necessitates the development of more effective diagnostic tools and therapeutic interventions, propelling the neuroscience market forward.

The aging population worldwide is another factor contributing to the rising demand for neurological solutions. As people live longer, the incidence of age-related neurodegenerative diseases increases. This trend underscores the need for early detection and treatment of neurological conditions, creating a fertile ground for the neuroscience market to flourish.

Neuroscience Industry Segmentation as Follows:

By Component

  • Instruments
  • Consumables
  • Software & Services

By Technology

  • Brain Imaging
  • Neuro-Microscopy
  • Stereotaxic Surgeries
  • Neuro-Proteomic Analysis
  • Neuro-Cellular Manipulation
  • Others

By End User

  • Hospitals
  • Diagnostic laboratories
  • Research and Academic Institute

Segment Analysis:

Neuroscience technology can be segmented by its approach to studying and manipulating the nervous system. Brain imaging, encompassing techniques like MRI and PET scans, holds the largest market share at roughly 40%, offering a non-invasive view of brain structure and function. Neuro-microscopy, zooming in on individual neurons, claims around 15%, crucial for detailed cellular analysis. Stereotaxic surgeries, precisely targeting brain regions for treatment or research, make up 10%. Neuro-proteomic analysis, exploring protein expression in the brain, and neuro-cellular manipulation techniques like optogenetics each capture around 5% of the market, offering powerful but specialized functionalities. The remaining 15% encompasses a diverse range of emerging technologies constantly shaping the field of neuroscience. This segmentation allows researchers and companies to target specific needs within the ever-growing neuroscience market.

Ask Sample PDF to see the structure of Report @ https://www.snsinsider.com/sample-request/3936

Regional Analysis:

  • North America (38.6% revenue share in 2023): Largest market propelled by advanced healthcare infrastructure, robust R&D activities
  • Europe (27.9%): Growing prevalence of age-related neurological disorders, focus on developing novel therapies contributing to market growth
  • Asia Pacific (21.4%): Rapidly expanding market due to increasing disposable incomes, improving healthcare facilities

Recent Developments:

  • In 2023, Biogen received FDA approval for a novel Alzheimer’s therapy, expanding treatment options for the cognitive disorder
  • Roche and Prothena partnered in 2022 to develop new therapies for Parkinson’s disease and other neurodegenerative disorders
  • Increasing R&D in areas like regenerative medicine, brain-computer interfaces, and digital therapeutics for neurological conditions

Key Takeaways:

  • Increasing prevalence of neurological diseases like Alzheimer’s, Parkinson’s, and rising investments in neuroscience R&D are major growth drivers
  • The neurology segment accounted for the largest revenue share in 2023 driven by growing demand for treatments for neurological conditions
  • North America dominated the market in 2023 owing to high healthcare spending, strong pipeline of neuroscience therapeutics
  • Asia Pacific is anticipated to register the highest CAGR from 2024-2031 driven by increasing healthcare access, rising disease burden

Purchase Neuroscience Market Report @ https://www.snsinsider.com/checkout/3936

Table of Content

Chapter 1 Introduction

Chapter 2 Research Methodology

Chapter 3 Neuroscience Market Dynamics

Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)

Chapter 5 Value Chain Analysis

Chapter 6 Porter’s 5 forces model

Chapter 7 PEST Analysis

Chapter 8 Neuroscience Market Segmentation, By Component

Chapter 9 Neuroscience Market Segmentation, By Technology

Chapter 10 Neuroscience Market Segmentation, By End User

Chapter 11 Regional Analysis

Chapter 12 Company profile

Chapter 13 Competitive Landscape

Chapter 14 Use Case and Best Practices

Chapter 15 Conclusion


Have Any Query? Ask Our Experts @ https://www.snsinsider.com/enquiry/3936

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[Protected Email],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com/